High-Spec™ Validation

Custom-Designed Immunologics’s High-Spec™ MAbs are created using the Fast-MAb™ production platform developed at Custom-Designed Immunologics, Each monoclonal antibody will undergo a four-fold and highly rigorous series of characterization steps to validate the monoclonal antibody, which includes traditional evaluations such as ELISA and Western blots. However, the key feature of High-Spec™ MAbs produced by Custom-Designed Immunologics is their unparalleled specificity conferred by a proprietary, unpresedented validation step that will ensure that end users can truly select the right antibody for the right application.

CDI’s MAb Characterization Process:

• Proprietary validation step
• Isotype identification
• ELISA performance (standard)
• Western blot analysis (standard)